Ocular Therapeutix(OCUL) - 2023 Q2 - Earnings Call Transcript

Thank you. Please hold for our next question. Our next question comes from Jon Wolleben of JMP. Hi. Good afternoon. Thanks for taking the questions. A couple from me on the wet AMD trial. Just wondering how you're thinking about measuring visual acuity as a primary, when you'd be collecting that data and when we could be seeing data from the first pivotal? I'm wondering about the formulation you're going to be choosing for this trial and if you're thinking about an identical design for the subsequent pivota ...